Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses, is pleased to announce that its CEO and Managing Director Riccardo Canevari will present at the annual Biotech Showcase™ event, being held 10-12 and 17-19 January 2022.
Mr Canevari will present Radiopharm Theranostics to attendees of the virtual event, traditionally held in San Francisco. The presentation will focus on the untapped potential of therapeutic radiopharmaceuticals as an emerging pillar in oncology and how Radiopharm Theranostics is well positioned to become a future leader in this sector due to the uniqueness of its pipeline breadth and depth.
The company presentations are available on demand to all registered attendees.
For more information, download the attached PDF.
Download this document
